{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 90394, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:03:07Z", "timestamp": 1574496187067}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 4, 15]]}, "DOI": "10.1158/1538-7445.am2012-4833", "type": "proceedings-article", "created": {"date-parts": [[2012, 8, 9]], "date-time": "2012-08-09T22:35:19Z", "timestamp": 1344551719000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Abstract 4833: Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutics antibody cetuximab"], "prefix": "10.1158", "author": [{"given": "Kimio", "family": "Yonesaka", "sequence": "first", "affiliation": []}, {"given": "Isamu", "family": "Okamoto", "sequence": "additional", "affiliation": []}, {"given": "Satoh", "family": "Taroh", "sequence": "additional", "affiliation": []}, {"given": "Kreshnik", "family": "Zejnullahu", "sequence": "additional", "affiliation": []}, {"given": "Kazuto", "family": "Nishio", "sequence": "additional", "affiliation": []}, {"given": "Masahiro", "family": "Fukuoka", "sequence": "additional", "affiliation": []}, {"given": "Pasi A.", "family": "Janne", "sequence": "additional", "affiliation": []}, {"given": "Kazuhiko", "family": "Nakagawa", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 21]]}, "event": {"name": "Proceedings: AACR 103rd Annual Meeting 2012\u2010\u2010 Mar 31\u2010Apr 4, 2012; Chicago, IL"}, "container-title": ["Experimental and Molecular Therapeutics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2012-4833", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T19:22:47Z", "timestamp": 1558207367000}, "score": 68.765884, "issued": {"date-parts": [[2012, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2012-4833"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2012-4833"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T11:24:03Z", "timestamp": 1574421843692}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 10, 1]], "date-time": "2011-10-01T00:00:00Z", "timestamp": 1317427200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[2011, 10]]}, "DOI": "10.1016/s0959-8049(11)72627-2", "type": "journal-article", "created": {"date-parts": [[2011, 11, 23]], "date-time": "2011-11-23T23:49:01Z", "timestamp": 1322092141000}, "page": "S10", "source": "Crossref", "is-referenced-by-count": 1, "title": ["OP 85 Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab"], "prefix": "10.1016", "volume": "47", "author": [{"given": "K.", "family": "Yonesaka", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "Zejnullahu", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Okamoto", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Satoh", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Cappuzzo", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Souglakos", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Engelman", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Varella-Garcia", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "J\u00e4nne", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804911726272?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804911726272?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 28]], "date-time": "2018-11-28T07:57:33Z", "timestamp": 1543391853000}, "score": 62.046387, "issued": {"date-parts": [[2011, 10]]}, "references-count": 0, "alternative-id": ["S0959804911726272"], "URL": "http://dx.doi.org/10.1016/s0959-8049(11)72627-2", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T11:23:26Z", "timestamp": 1576841006415}, "reference-count": 38, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "99", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science Translational Medicine"], "published-print": {"date-parts": [[2011, 9, 7]]}, "DOI": "10.1126/scitranslmed.3002442", "type": "journal-article", "created": {"date-parts": [[2011, 9, 7]], "date-time": "2011-09-07T19:10:32Z", "timestamp": 1315422632000}, "page": "99ra86-99ra86", "source": "Crossref", "is-referenced-by-count": 263, "title": ["Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab"], "prefix": "10.1126", "volume": "3", "author": [{"given": "K.", "family": "Yonesaka", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "Zejnullahu", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Okamoto", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Satoh", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Cappuzzo", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Souglakos", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Ercan", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Rogers", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Roncalli", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Takeda", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Fujisaka", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Philips", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Shimizu", "sequence": "additional", "affiliation": []}, {"given": "O.", "family": "Maenishi", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Cho", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Destro", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Taira", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Takeda", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Okabe", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Swanson", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Itoh", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Takada", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Lifshits", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Okuno", "sequence": "additional", "affiliation": []}, {"given": "J. A.", "family": "Engelman", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "Shivdasani", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nishio", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Fukuoka", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Varella-Garcia", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "P. A.", "family": "Janne", "sequence": "additional", "affiliation": []}], "member": "221", "published-online": {"date-parts": [[2011, 9, 7]]}, "reference": [{"issue": "20", "key": "1_29836286", "doi-asserted-by": "publisher", "first-page": "2040", "DOI": "10.1056/NEJMoa071834", "volume": "357", "author": "Jonker", "year": "2007", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "11", "key": "2_31844636", "doi-asserted-by": "publisher", "first-page": "1116", "DOI": "10.1056/NEJMoa0802656", "volume": "359", "author": "Vermorken", "year": "2008", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "9674", "key": "3_34742974", "doi-asserted-by": "publisher", "first-page": "1525", "DOI": "10.1016/S0140-6736(09)60569-9", "volume": "373", "author": "Pirker", "year": "2009", "journal-title": "Lancet", "ISSN": "http://id.crossref.org/issn/0140-6736", "issn-type": "print"}, {"issue": "8", "key": "4_28951313", "doi-asserted-by": "publisher", "first-page": "1275", "DOI": "10.1111/j.1349-7006.2007.00510.x", "volume": "98", "author": "Kimura", "year": "2007", "journal-title": "Cancer Science", "ISSN": "http://id.crossref.org/issn/0910-5050", "issn-type": "print"}, {"issue": "14", "key": "5_34429726", "doi-asserted-by": "publisher", "first-page": "1408", "DOI": "10.1056/NEJMoa0805019", "volume": "360", "author": "Van Cutsem", "year": "2009", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "5", "key": "6_33080693", "doi-asserted-by": "publisher", "first-page": "663", "DOI": "10.1200/JCO.2008.20.8397", "volume": "27", "year": "2009", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "6", "key": "7_33736820", "doi-asserted-by": "publisher", "first-page": "563", "DOI": "10.1056/NEJMoa0808268", "volume": "360", "author": "Tol", "year": "2009", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "12", "key": "8_33844478", "doi-asserted-by": "publisher", "first-page": "2091", "DOI": "10.1200/JCO.2009.21.9170", "volume": "27", "year": "2009", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "35", "key": "9_32577915", "doi-asserted-by": "publisher", "first-page": "5705", "DOI": "10.1200/JCO.2008.18.0786", "volume": "26", "year": "2008", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "8", "key": "10_37629045", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1016/S1470-2045(10)70130-3", "volume": "11", "author": "De Roock", "year": "2010", "journal-title": "The lancet oncology", "ISSN": "http://id.crossref.org/issn/1470-2045", "issn-type": "print"}, {"issue": "17", "key": "11_32203977", "doi-asserted-by": "publisher", "first-page": "1757", "DOI": "10.1056/NEJMoa0804385", "volume": "359", "author": "Karapetis", "year": "2008", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "5827", "key": "12_28472812", "doi-asserted-by": "publisher", "first-page": "1039", "DOI": "10.1126/science.1141478", "volume": "316", "year": "2007", "journal-title": "Science", "ISSN": "http://id.crossref.org/issn/0036-8075", "issn-type": "print"}, {"issue": "10", "key": "13_22459199", "doi-asserted-by": "publisher", "first-page": "2695", "DOI": "10.1172/JCI28656", "volume": "116", "year": "2006", "journal-title": "Journal of Clinical Investigation", "ISSN": "http://id.crossref.org/issn/0021-9738", "issn-type": "print"}, {"issue": "16", "key": "14_19333464", "doi-asserted-by": "publisher", "first-page": "1185", "DOI": "10.1093/jnci/dji238", "volume": "97", "author": "Mukohara", "year": "2005", "journal-title": "JNCI Journal of the National Cancer Institute", "ISSN": "http://id.crossref.org/issn/0027-8874", "issn-type": "print"}, {"issue": "4", "key": "15_6470940", "doi-asserted-by": "crossref", "first-page": "904", "DOI": "10.1200/JCO.2000.18.4.904", "volume": "18", "author": "Baselga", "year": "2000", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "1", "key": "16_36617060", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/j.ccr.2009.11.022", "volume": "17", "author": "Turke", "year": "2010", "journal-title": "Cancer cell", "ISSN": "http://id.crossref.org/issn/1535-6108", "issn-type": "print"}, {"issue": "21", "key": "17_32396939", "doi-asserted-by": "publisher", "first-page": "6963", "DOI": "10.1158/1078-0432.CCR-08-0957", "volume": "14", "author": "Yonesaka", "year": "2008", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "23", "key": "18_23353659", "doi-asserted-by": "publisher", "first-page": "6793", "DOI": "10.1093/emboj/20.23.6793", "volume": "20", "author": "Li", "year": "2001", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "7", "key": "19_35092823", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1038/nrc2656", "volume": "9", "author": "Baselga", "year": "2009", "journal-title": "Nature reviews. Cancer", "ISSN": "http://id.crossref.org/issn/1474-175X", "issn-type": "print"}, {"issue": "10", "key": "20_19688808", "doi-asserted-by": "publisher", "first-page": "3788", "DOI": "10.1073/pnas.0409773102", "volume": "102", "year": "2005", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "4", "key": "21_18142213", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1016/S1535-6108(04)00083-2", "volume": "5", "author": "Franklin", "year": "2004", "journal-title": "Cancer cell", "ISSN": "http://id.crossref.org/issn/1535-6108", "issn-type": "print"}, {"issue": "15", "key": "22_31014969", "doi-asserted-by": "publisher", "first-page": "2442", "DOI": "10.1200/JCO.2007.14.8494", "volume": "26", "year": "2008", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "33", "key": "23_35847305", "doi-asserted-by": "publisher", "first-page": "5552", "DOI": "10.1200/JCO.2008.21.1763", "volume": "27", "year": "2009", "journal-title": "Journal of Clinical Oncology", "ISSN": "http://id.crossref.org/issn/0732-183X", "issn-type": "print"}, {"issue": "2", "key": "24_18637051", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1093/annonc/mdi059", "volume": "16", "author": "Fornier", "year": "2005", "journal-title": "Annals of Oncology", "ISSN": "http://id.crossref.org/issn/0923-7534", "issn-type": "print"}, {"issue": "5", "key": "25_35903737", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1016/j.ccr.2009.09.028", "volume": "16", "author": "O'Hare", "year": "2009", "journal-title": "Cancer cell", "ISSN": "http://id.crossref.org/issn/1535-6108", "issn-type": "print"}, {"issue": "24", "key": "26_37403185", "doi-asserted-by": "publisher", "first-page": "2260", "DOI": "10.1056/NEJMoa1002315", "volume": "362", "year": "2010", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "8", "key": "27_18698201", "doi-asserted-by": "publisher", "first-page": "786", "DOI": "10.1056/NEJMoa044238", "volume": "352", "author": "Kobayashi", "year": "2005", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "3", "key": "28_18952488", "doi-asserted-by": "publisher", "first-page": "e73", "DOI": "10.1371/journal.pmed.0020073", "volume": "2", "author": "Pao", "year": "2005", "ISSN": "http://id.crossref.org/issn/1549-1277", "issn-type": "print"}, {"issue": "28", "key": "29_31388579", "doi-asserted-by": "publisher", "first-page": "3944", "DOI": "10.1038/onc.2008.19", "volume": "27", "author": "Wheeler", "year": "2008", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "6", "key": "30_36752003", "doi-asserted-by": "publisher", "first-page": "2485", "DOI": "10.1158/0008-5472.CAN-09-3145", "volume": "70", "year": "2010", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "16", "key": "31_29208355", "doi-asserted-by": "publisher", "first-page": "4909", "DOI": "10.1158/1078-0432.CCR-07-0701", "volume": "13", "author": "Ritter", "year": "2007", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "14", "key": "32_29043838", "doi-asserted-by": "publisher", "first-page": "6825", "DOI": "10.1158/0008-5472.CAN-07-0765", "volume": "67", "author": "Piechocki", "year": "2007", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "4", "key": "33_10792629", "first-page": "909", "volume": "5", "author": "Ciardiello", "year": "1999", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "17", "key": "34_11295274", "first-page": "6500", "volume": "61", "author": "Albanell", "year": "2001", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "13", "key": "35_19074253", "doi-asserted-by": "publisher", "first-page": "5561", "DOI": "10.1158/0008-5472.CAN-04-4603", "volume": "65", "author": "Zhao", "year": "2005", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "7276", "key": "36_36309163", "doi-asserted-by": "publisher", "first-page": "1070", "DOI": "10.1038/nature08622", "volume": "462", "author": "Zhou", "year": "2009", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "34", "key": "37_31730120", "doi-asserted-by": "publisher", "first-page": "12480", "DOI": "10.1073/pnas.0803217105", "volume": "105", "year": "2008", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "24", "key": "38_30096368", "doi-asserted-by": "publisher", "first-page": "11924", "DOI": "10.1158/0008-5472.CAN-07-1885", "volume": "67", "author": "Engelman", "year": "2007", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}], "container-title": ["Science Translational Medicine"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/scitranslmed.3002442", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 15]], "date-time": "2019-06-15T03:07:32Z", "timestamp": 1560568052000}, "score": 41.66757, "issued": {"date-parts": [[2011, 9, 7]]}, "references-count": 38, "journal-issue": {"published-online": {"date-parts": [[2011, 9, 7]]}, "published-print": {"date-parts": [[2011, 9, 7]]}, "issue": "99"}, "URL": "http://dx.doi.org/10.1126/scitranslmed.3002442", "relation": {"cites": []}, "ISSN": ["1946-6234", "1946-6242"], "issn-type": [{"value": "1946-6234", "type": "print"}, {"value": "1946-6242", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:58:13Z", "timestamp": 1574755093315}, "reference-count": 15, "publisher": "Japan Lung Cancer Society", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JJLC", "Haigan", "Japanese Journal of Lung Cancer"], "published-print": {"date-parts": [[2015]]}, "DOI": "10.2482/haigan.55.948", "type": "journal-article", "created": {"date-parts": [[2016, 1, 5]], "date-time": "2016-01-05T22:04:40Z", "timestamp": 1452031480000}, "page": "948-955", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Anti-HER3 Antibody Patritumab Overcomes Resistance to EGFR Inhibitor in Non-small Cell Lung Cancer"], "prefix": "10.2482", "volume": "55", "author": [{"given": "Kimio", "family": "Yonesaka", "sequence": "first", "affiliation": [{"name": "Department of Medical Oncology, Kinki University Faculty of Medicine"}]}], "member": "1322", "container-title": ["Haigan"], "original-title": ["\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u304a\u3051\u308b\u6297HER3\u6297\u4f53patritumab\u306b\u3088\u308bEGFR\u963b\u5bb3\u5264\u8010\u6027\u306e\u514b\u670d\u306b\u3064\u3044\u3066"], "language": "en", "link": [{"URL": "https://www.jstage.jst.go.jp/article/haigan/55/6/55_948/_pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 3]], "date-time": "2019-09-03T06:04:01Z", "timestamp": 1567490641000}, "score": 33.88615, "issued": {"date-parts": [[2015]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[2015]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.2482/haigan.55.948", "ISSN": ["0386-9628", "1348-9992"], "issn-type": [{"value": "0386-9628", "type": "print"}, {"value": "1348-9992", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:52:10Z", "timestamp": 1574218330787}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "13", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2006, 7, 1]]}, "DOI": "10.1158/1078-0432.ccr-05-2404", "type": "journal-article", "created": {"date-parts": [[2006, 7, 5]], "date-time": "2006-07-05T20:54:13Z", "timestamp": 1152132853000}, "page": "4103-4111", "source": "Crossref", "is-referenced-by-count": 145, "title": ["Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells"], "prefix": "10.1158", "volume": "12", "author": [{"given": "K.", "family": "Erjala", "sequence": "first", "affiliation": []}], "member": "1086", "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-05-2404", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T11:52:08Z", "timestamp": 1482493928000}, "score": 29.205582, "issued": {"date-parts": [[2006, 7, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 7, 1]]}, "issue": "13"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-05-2404", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T05:08:05Z", "timestamp": 1575522485241}, "reference-count": 32, "publisher": "Springer Science and Business Media LLC", "issue": "10", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T00:00:00Z", "timestamp": 1569801600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Oncogenesis"], "published-print": {"date-parts": [[2019, 10]]}, "DOI": "10.1038/s41389-019-0164-9", "type": "journal-article", "created": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T16:10:48Z", "timestamp": 1569859848000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI"], "prefix": "10.1038", "volume": "8", "author": [{"ORCID": "http://orcid.org/0000-0002-0816-5315", "authenticated-orcid": false, "given": "Kimio", "family": "Yonesaka", "sequence": "first", "affiliation": []}, {"given": "Kaoru", "family": "Tanaka", "sequence": "additional", "affiliation": []}, {"given": "Mutsukazu", "family": "Kitano", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0002-3280-4850", "authenticated-orcid": false, "given": "Hisato", "family": "Kawakami", "sequence": "additional", "affiliation": []}, {"given": "Hidetoshi", "family": "Hayashi", "sequence": "additional", "affiliation": []}, {"given": "Masayuki", "family": "Takeda", "sequence": "additional", "affiliation": []}, {"given": "Kazuko", "family": "Sakai", "sequence": "additional", "affiliation": []}, {"given": "Kazuto", "family": "Nishio", "sequence": "additional", "affiliation": []}, {"given": "Katsumi", "family": "Doi", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0003-1284-9776", "authenticated-orcid": false, "given": "Kazuhiko", "family": "Nakagawa", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 9, 30]]}, "reference": [{"key": "164_CR1", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/j.coms.2014.01.001", "volume": "26", "author": "N Vigneswaran", "year": "2014", "unstructured": "Vigneswaran, N. & Williams, M. D. Epidemiological trends in head and neck cancer and aids in diagnosis. Oral. Maxillofac. Surg. Clin. North Am. 26, 123\u2013141 (2014).", "journal-title": "Oral. Maxillofac. Surg. Clin. North Am."}, {"key": "164_CR2", "doi-asserted-by": "publisher", "first-page": "1116", "DOI": "10.1056/NEJMoa0802656", "volume": "359", "author": "JB Vermorken", "year": "2008", "unstructured": "Vermorken, J. B. et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med 359, 1116\u20131127 (2008).", "journal-title": "N. Engl. J. Med"}, {"key": "164_CR3", "doi-asserted-by": "publisher", "first-page": "676", "DOI": "10.1177/0194599811399559", "volume": "144", "author": "TD Reeves", "year": "2011", "unstructured": "Reeves, T. D., Hill, E. G., Armeson, K. E. & Gillespie, M. B. Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data. Otolaryngol.-Head. Neck Surg. 144, 676\u2013684 (2011).", "journal-title": "Otolaryngol.-Head. Neck Surg."}, {"key": "164_CR4", "doi-asserted-by": "publisher", "first-page": "1856", "DOI": "10.1056/NEJMoa1602252", "volume": "375", "author": "RL Ferris", "year": "2016", "unstructured": "Ferris, R. L. et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N. Engl. J. Med 375, 1856\u20131867 (2016).", "journal-title": "N. Engl. J. Med"}, {"key": "164_CR5", "doi-asserted-by": "publisher", "first-page": "1348", "DOI": "10.1016/S0959-8049(03)00235-1", "volume": "39", "author": "F Ciardiello", "year": "2003", "unstructured": "Ciardiello, F. & Tortora, G. Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur. J. Cancer 39, 1348\u20131354 (2003).", "journal-title": "Eur. J. Cancer"}, {"key": "164_CR6", "doi-asserted-by": "publisher", "first-page": "824", "DOI": "10.1093/jnci/90.11.824", "volume": "90", "author": "J Rubin Grandis", "year": "1998", "unstructured": "Rubin Grandis, J. et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst. 90, 824\u2013832 (1998).", "journal-title": "J. Natl. Cancer Inst."}, {"key": "164_CR7", "doi-asserted-by": "publisher", "first-page": "4170", "DOI": "10.1200/JCO.2006.07.2587", "volume": "24", "author": "CH Chung", "year": "2006", "unstructured": "Chung, C. H. et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J. Clin. Oncol. 24, 4170\u20134176 (2006).", "journal-title": "J. Clin. Oncol."}, {"key": "164_CR8", "doi-asserted-by": "publisher", "first-page": "775", "DOI": "10.1016/S0092-8674(02)00963-7", "volume": "110", "author": "H Ogiso", "year": "2002", "unstructured": "Ogiso, H. et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775\u2013787 (2002).", "journal-title": "Cell"}, {"key": "164_CR9", "doi-asserted-by": "publisher", "first-page": "763", "DOI": "10.1016/S0092-8674(02)00940-6", "volume": "110", "author": "TP Garrett", "year": "2002", "unstructured": "Garrett, T. P. et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110, 763\u2013773 (2002).", "journal-title": "Cell"}, {"key": "164_CR10", "doi-asserted-by": "publisher", "first-page": "6963", "DOI": "10.1158/1078-0432.CCR-08-0957", "volume": "14", "author": "K Yonesaka", "year": "2008", "unstructured": "Yonesaka, K. et al. Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers. Clin. Cancer Res 14, 6963\u20136973 (2008).", "journal-title": "Clin. Cancer Res"}, {"key": "164_CR11", "doi-asserted-by": "publisher", "first-page": "3230", "DOI": "10.1200/JCO.2006.10.5437", "volume": "25", "author": "S Khambata-Ford", "year": "2007", "unstructured": "Khambata-Ford, S. et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J. Clin. Oncol. 25, 3230\u20133237 (2007).", "journal-title": "J. Clin. Oncol."}, {"key": "164_CR12", "doi-asserted-by": "publisher", "first-page": "1408", "DOI": "10.1056/NEJMoa0805019", "volume": "360", "author": "E Cutsem Van", "year": "2009", "unstructured": "Van Cutsem, E. et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. New Engl. J. Med. 360, 1408\u20131417 (2009).", "journal-title": "New Engl. J. Med."}, {"key": "164_CR13", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.1056/NEJMoa033025", "volume": "351", "author": "D Cunningham", "year": "2004", "unstructured": "Cunningham, D. et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. New Engl. J. Med. 351, 337\u2013345 (2004).", "journal-title": "New Engl. J. Med"}, {"key": "164_CR14", "doi-asserted-by": "publisher", "first-page": "1525", "DOI": "10.1016/S0140-6736(09)60569-9", "volume": "373", "author": "R Pirker", "year": "2009", "unstructured": "Pirker, R. et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 373, 1525\u20131531 (2009).", "journal-title": "Lancet"}, {"key": "164_CR15", "doi-asserted-by": "publisher", "first-page": "2171", "DOI": "10.1200/JCO.2006.06.7447", "volume": "25", "author": "JB Vermorken", "year": "2007", "unstructured": "Vermorken, J. B. et al. Open-label, uncontrolled, multicenter Phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J. Clin. Oncol. 25, 2171\u20132177 (2007).", "journal-title": "J. Clin. Oncol."}, {"key": "164_CR16", "doi-asserted-by": "publisher", "first-page": "2489", "DOI": "10.1158/1078-0432.CCR-09-2318", "volume": "16", "author": "LF Chen", "year": "2010", "unstructured": "Chen, L. F., Cohen, E. E. W. & Grandis, J. R. New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors. Clin. Cancer Res. 16, 2489\u20132495 (2010).", "journal-title": "Clin. Cancer Res"}, {"key": "164_CR17", "doi-asserted-by": "publisher", "first-page": "99ra86", "DOI": "10.1126/scitranslmed.3002442", "volume": "3", "author": "K Yonesaka", "year": "2011", "unstructured": "Yonesaka, K. et al. Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci. Transl. Med. 3, 99ra86 (2011).", "journal-title": "Sci. Transl. Med"}, {"key": "164_CR18", "doi-asserted-by": "publisher", "first-page": "922", "DOI": "10.1158/2159-8290.CD-12-0108", "volume": "2", "author": "K Takezawa", "year": "2012", "unstructured": "Takezawa, K. et al. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Cancer Disco. 2, 922\u2013933 (2012).", "journal-title": "Cancer Disco."}, {"key": "164_CR19", "first-page": "30904", "volume": "1470-2045", "author": "F Meric-Bernstam", "year": "2019", "unstructured": "Meric-Bernstam, F. et al. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 1470-2045, 30904\u201330905 (2019).", "journal-title": "Lancet Oncol."}, {"key": "164_CR20", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1248/cpb.c18-00744", "volume": "67", "author": "T Nakada", "year": "2019", "unstructured": "Nakada, T., Sugihara, K., Jikoh, T., Abe, Y. & Agatsuma, T. The latest research and development into the antibody\u2013drug conjugate, [fam-] trastuzumab deruxtecan (ds-8201a), for HER2 cancer therapy. Chem. Pharm. Bull. 67, 173\u2013185 (2019).", "journal-title": "Chem. Pharm. Bull."}, {"key": "164_CR21", "first-page": "67", "volume": "4", "author": "EL Stewart", "year": "2015", "unstructured": "Stewart, E. L., Tan, S. Z., Liu, G. & Tsao, M. S. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations\u2014a review. Transl. Lung Cancer Res. 4, 67 (2015).", "journal-title": "Transl. Lung Cancer Res"}, {"key": "164_CR22", "doi-asserted-by": "publisher", "first-page": "1864", "DOI": "10.1200/JCO.2008.17.0530", "volume": "27", "author": "JS Stewart", "year": "2009", "unstructured": "Stewart, J. S. et al. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. J. Clin. Oncol. 27, 1864\u20131871 (2009).", "journal-title": "J. Clin. Oncol."}, {"key": "164_CR23", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1517/13543784.2014.858696", "volume": "23", "author": "R Ferrarotto", "year": "2014", "unstructured": "Ferrarotto, R. & Gold, K. A. Afatinib in the treatment of head and neck squamous cell carcinoma. Exp. Opin. Invest Drug 23, 135\u2013143 (2014).", "journal-title": "Exp. Opin. Invest Drug"}, {"key": "164_CR24", "doi-asserted-by": "publisher", "first-page": "735", "DOI": "10.1080/13543784.2016.1177022", "volume": "25", "author": "O Elicin", "year": "2016", "unstructured": "Elicin, O. & Ozsahin, M. Current role of dacomitinib in head and neck cancer. Exp. Opin. Invest Drug 25, 735\u2013742 (2016).", "journal-title": "Exp. Opin. Invest Drug"}, {"key": "164_CR25", "doi-asserted-by": "publisher", "first-page": "33602", "DOI": "10.18632/oncotarget.5286", "volume": "6", "author": "K Yonesaka", "year": "2015", "unstructured": "Yonesaka, K. et al. The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer. Oncotarget 6, 33602 (2015).", "journal-title": "Oncotarget"}, {"key": "164_CR26", "doi-asserted-by": "publisher", "first-page": "878", "DOI": "10.1038/onc.2015.142", "volume": "35", "author": "K Yonesaka", "year": "2016", "unstructured": "Yonesaka, K. et al. Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib. Oncogene 35, 878 (2016).", "journal-title": "Oncogene"}, {"key": "164_CR27", "doi-asserted-by": "publisher", "first-page": "11847", "DOI": "10.18632/oncotarget.2663", "volume": "5", "author": "H Kawakami", "year": "2014", "unstructured": "Kawakami, H. et al. The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells. Oncotarget 5, 11847 (2014).", "journal-title": "Oncotarget"}, {"key": "164_CR28", "doi-asserted-by": "publisher", "first-page": "372", "DOI": "10.3109/07853890.2014.912836", "volume": "46", "author": "M Martini", "year": "2014", "unstructured": "Martini, M., De Santis, M. C., Braccini, L., Gulluni, F. & Hirsch, E. PI3K/AKT signaling pathway and cancer: an updated review. Ann. Med. 46, 372\u2013383 (2014).", "journal-title": "Ann. Med"}, {"key": "164_CR29", "doi-asserted-by": "publisher", "first-page": "4602", "DOI": "10.1158/1078-0432.CCR-16-2738", "volume": "23", "author": "JM Xu", "year": "2017", "unstructured": "Xu, J. M. et al. PIK3CA mutations contribute to acquired cetuximab resistance in patients with metastatic colorectal cancer. Clin. Cancer Res. 23, 4602\u20134616 (2017).", "journal-title": "Clin. Cancer Res"}, {"key": "164_CR30", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1016/S1470-2045(15)70124-5", "volume": "16", "author": "JPH Machiels", "year": "2015", "unstructured": "Machiels, J. P. H. et al. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial. Lancet Oncol. 16, 583\u2013594 (2015).", "journal-title": "Lancet Oncol."}, {"key": "164_CR31", "author": "DS Shames", "volume": "8", "year": "2013", "unstructured": "Shames, D. S. et al. High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck. PLoS ONE 8, e56765 (2013).", "journal-title": "PLoS ONE", "DOI": "10.1371/journal.pone.0056765", "doi-asserted-by": "publisher"}, {"key": "164_CR32", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/j.ymeth.2014.04.006", "volume": "70", "author": "A Cassidy", "year": "2014", "unstructured": "Cassidy, A. & Jones, J. Developments in in situ hybridisation. Methods 70, 39\u201345 (2014).", "journal-title": "Methods"}], "container-title": ["Oncogenesis"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41389-019-0164-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41389-019-0164-9", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41389-019-0164-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T16:13:33Z", "timestamp": 1569860013000}, "score": 28.759373, "issued": {"date-parts": [[2019, 9, 30]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2019, 10]]}, "issue": "10"}, "alternative-id": ["164"], "URL": "http://dx.doi.org/10.1038/s41389-019-0164-9", "relation": {"cites": []}, "ISSN": ["2157-9024"], "issn-type": [{"value": "2157-9024", "type": "electronic"}], "subject": ["Cancer Research", "Molecular Biology"], "assertion": [{"value": "14 May 2019", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "10 September 2019", "order": 2, "name": "revised", "label": "Revised", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "12 September 2019", "order": 3, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "30 September 2019", "order": 4, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "Yonesaka reports grants and personal fees from Boehringer Ingelheim. Hayashi reports grants and personal fees from Boehringer Ingelheim and AstraZeneca. Takeda reports personal fees from Boehringer Ingelheim. Tanaka reports personal fees from Boehringer Ingelheim, AstraZeneca, and Bristol-Myers Squibb. Nishio reports grants from Boehringer Ingelheim. Nakagawa reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Astellas Pharma, Bristol-Myers Squibb, and Daiichi-sankyo, and personal fees from Pfizer. The remaining authors declare that they have no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of interest"}}], "article-number": "54"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T11:49:24Z", "timestamp": 1574855364604}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "11", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 11, 1]], "date-time": "2017-11-01T00:00:00Z", "timestamp": 1509494400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2018, 11, 2]], "date-time": "2018-11-02T00:00:00Z", "timestamp": 1541116800000}, "delay-in-days": 366, "content-version": "vor"}], "content-domain": {"domain": ["jto.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Thoracic Oncology"], "published-print": {"date-parts": [[2017, 11]]}, "DOI": "10.1016/j.jtho.2017.09.1884", "type": "journal-article", "created": {"date-parts": [[2017, 11, 7]], "date-time": "2017-11-07T06:01:13Z", "timestamp": 1510034473000}, "page": "S2371-S2372", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["PUB021 SLK Causes Resistance to EGFR-TKI in Lung Cancer"], "prefix": "10.1016", "volume": "12", "author": [{"given": "K.", "family": "Ashraf", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Thoracic Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1556086417326199?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1556086417326199?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 12]], "date-time": "2018-11-12T19:12:58Z", "timestamp": 1542049978000}, "score": 26.231382, "issued": {"date-parts": [[2017, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 11]]}, "issue": "11"}, "alternative-id": ["S1556086417326199"], "URL": "http://dx.doi.org/10.1016/j.jtho.2017.09.1884", "ISSN": ["1556-0864"], "issn-type": [{"value": "1556-0864", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "PUB021 SLK Causes Resistance to EGFR-TKI in Lung Cancer", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Thoracic Oncology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jtho.2017.09.1884", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2017 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:38:16Z", "timestamp": 1574707096250}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 5, 1]], "date-time": "2012-05-01T00:00:00Z", "timestamp": 1335830400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1016/s0016-5085(12)61973-8", "type": "journal-article", "created": {"date-parts": [[2015, 6, 27]], "date-time": "2015-06-27T09:24:22Z", "timestamp": 1435397062000}, "page": "S-515", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Su1832 Cetuximab and Panitumumab Do Not Inhibit Reg4-CD44-Mediated Activation of EGFR in Colorectal Cancer Cells"], "prefix": "10.1016", "volume": "142", "author": [{"given": "Kumar S.", "family": "Bishnupuri", "sequence": "first", "affiliation": []}, {"given": "Satheesh K.", "family": "Sainathan", "sequence": "additional", "affiliation": []}, {"given": "Wu", "family": "Jin", "sequence": "additional", "affiliation": []}, {"given": "Brian K.", "family": "Dieckgraefe", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0016508512619738?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0016508512619738?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 21]], "date-time": "2018-09-21T10:57:43Z", "timestamp": 1537527463000}, "score": 24.904766, "issued": {"date-parts": [[2012, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 5]]}, "issue": "5"}, "alternative-id": ["S0016508512619738"], "URL": "http://dx.doi.org/10.1016/s0016-5085(12)61973-8", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:46:57Z", "timestamp": 1574484417243}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 12, 10]]}, "DOI": "10.1158/1535-7163.targ-09-a177", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T06:38:29Z", "timestamp": 1340779109000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract A177: Cetuximab resistance associated with dimerization\u2010independence of oncogenic EGFR mutants"], "prefix": "10.1158", "author": [{"given": "Jeonghee", "family": "Cho", "sequence": "first", "affiliation": []}, {"given": "Liang", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "Naveen", "family": "Sangji", "sequence": "additional", "affiliation": []}, {"given": "Jinyan", "family": "Du", "sequence": "additional", "affiliation": []}, {"given": "Takafumi", "family": "Okabe", "sequence": "additional", "affiliation": []}, {"given": "Kimio", "family": "Yonesaka", "sequence": "additional", "affiliation": []}, {"given": "Joshua M.", "family": "Francis", "sequence": "additional", "affiliation": []}, {"given": "Richard J.", "family": "Flavin", "sequence": "additional", "affiliation": []}, {"given": "Soyoung", "family": "Yu", "sequence": "additional", "affiliation": []}, {"given": "Heidi E.", "family": "Greulich", "sequence": "additional", "affiliation": []}, {"given": "Bruce E.", "family": "Johnson", "sequence": "additional", "affiliation": []}, {"given": "Michael J.", "family": "Eck", "sequence": "additional", "affiliation": []}, {"given": "Pasi A.", "family": "J\u00e4nne", "sequence": "additional", "affiliation": []}, {"given": "Kwok\u2010Kin", "family": "Wong", "sequence": "additional", "affiliation": []}, {"given": "Matthew", "family": "Meyerson", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 10, 24]]}, "event": {"name": "Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA"}, "container-title": ["EGFR/Her2"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.TARG-09-A177", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T19:42:02Z", "timestamp": 1557430922000}, "score": 24.893467, "issued": {"date-parts": [[2009, 12, 10]]}, "references-count": 0, "alternative-id": ["10.1158/1535-7163.TARG-09-A177"], "URL": "http://dx.doi.org/10.1158/1535-7163.targ-09-a177"}, {"indexed": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T18:44:19Z", "timestamp": 1576608259530}, "reference-count": 44, "publisher": "Springer Science and Business Media LLC", "issue": "16", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 2, 1]], "date-time": "2010-02-01T00:00:00Z", "timestamp": 1264982400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2010, 4]]}, "DOI": "10.1038/onc.2009.526", "type": "journal-article", "created": {"date-parts": [[2010, 2, 1]], "date-time": "2010-02-01T11:17:03Z", "timestamp": 1265023023000}, "page": "2346-2356", "source": "Crossref", "is-referenced-by-count": 119, "title": ["Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor"], "prefix": "10.1038", "volume": "29", "author": [{"given": "D", "family": "Ercan", "sequence": "first", "affiliation": []}, {"given": "K", "family": "Zejnullahu", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Yonesaka", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Xiao", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Capelletti", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Rogers", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Lifshits", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Brown", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "J G", "family": "Christensen", "sequence": "additional", "affiliation": []}, {"given": "D J", "family": "Kwiatkowski", "sequence": "additional", "affiliation": []}, {"given": "J A", "family": "Engelman", "sequence": "additional", "affiliation": []}, {"given": "P A", "family": "J\u00e4nne", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 2, 1]]}, "reference": [{"key": "BFonc2009526_CR1", "doi-asserted-by": "publisher", "first-page": "110", "DOI": "10.1200/JCO.2002.20.1.110", "volume": "20", "author": "J Albanell", "year": "2002", "unstructured": "Albanell J, Rojo F, Averbuch S, Feyereislova A, Mascaro JM, Herbst R et al. (2002). Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 20: 110\u2013124.", "journal-title": "J Clin Oncol"}, {"key": "BFonc2009526_CR2", "doi-asserted-by": "publisher", "first-page": "6494", "DOI": "10.1158/1078-0432.CCR-06-1570", "volume": "12", "author": "MN Balak", "year": "2006", "unstructured": "Balak MN, Gong Y, Riely GJ, Somwar R, Li AR, Zakowski MF et al. (2006). Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clin Cancer Res 12: 6494\u20136501.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2009526_CR3", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1016/S1359-6349(08)72135-9", "volume": "6", "author": "B Besse", "year": "2008", "unstructured": "Besse B, Eaton Kd, Soira JC, Lynch TJ, Miller V, Wong KK et al. (2008). Neratinib (HKI272) an irreversible pan-ErbB receptor tyrosine kinase inhibtor: preliminary results of a phase 2 tiral in patients with advanced non-small cell lung cancer. Euro J Cancer 6: 64; abstract 203..", "journal-title": "Euro J Cancer"}, {"key": "BFonc2009526_CR4", "doi-asserted-by": "publisher", "first-page": "2332", "DOI": "10.1182/blood-2006-02-004580", "volume": "108", "author": "HA Bradeen", "year": "2006", "unstructured": "Bradeen HA, Eide CA, O'Hare T, Johnson KJ, Willis SG, Lee FY et al. (2006). Comparison of imatinib mesylate, dasatinib (BMS-354825) and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations. Blood 108: 2332\u20132338.", "journal-title": "Blood"}, {"key": "BFonc2009526_CR5", "doi-asserted-by": "publisher", "first-page": "11011", "DOI": "10.1073/pnas.0504952102", "volume": "102", "author": "TA Carter", "year": "2005", "unstructured": "Carter TA, Wodicka LM, Shah NP, Velasco AM, Fabian MA, Treiber DK et al. (2005). Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc Natl Acad Sci USA 102: 11011\u201311016.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2009526_CR6", "doi-asserted-by": "publisher", "first-page": "1201", "DOI": "10.1056/NEJMoa025217", "volume": "348", "author": "J Cools", "year": "2003", "unstructured": "Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. (2003). A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201\u20131214.", "journal-title": "N Engl J Med"}, {"key": "BFonc2009526_CR7", "doi-asserted-by": "publisher", "first-page": "1329", "DOI": "10.1016/S0140-6736(06)69446-4", "volume": "368", "author": "GD Demetri", "year": "2006", "unstructured": "Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J et al. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368: 1329\u20131338.", "journal-title": "Lancet"}, {"key": "BFonc2009526_CR8", "doi-asserted-by": "publisher", "first-page": "1038", "DOI": "10.1056/NEJM200104053441402", "volume": "344", "author": "BJ Druker", "year": "2001", "unstructured": "Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. (2001). Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344: 1038\u20131042.", "journal-title": "N Engl J Med"}, {"key": "BFonc2009526_CR9", "doi-asserted-by": "publisher", "first-page": "3788", "DOI": "10.1073/pnas.0409773102", "volume": "102", "author": "JA Engelman", "year": "2005", "unstructured": "Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C et al. (2005). ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci USA 102: 3788\u20133793.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2009526_CR10", "doi-asserted-by": "publisher", "first-page": "2695", "DOI": "10.1172/JCI28656", "volume": "116", "author": "JA Engelman", "year": "2006", "unstructured": "Engelman JA, Mukohara T, Zejnullahu K, Lifshits E, Borras AM, Gale CM et al. (2006). Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. J Clin Invest 116: 2695\u20132706.", "journal-title": "J Clin Invest"}, {"key": "BFonc2009526_CR11", "doi-asserted-by": "publisher", "first-page": "11924", "DOI": "10.1158/0008-5472.CAN-07-1885", "volume": "67", "author": "JA Engelman", "year": "2007", "unstructured": "Engelman JA, Zejnullahu K, Gale CM, Lifshits E, Gonzales AJ, Shimamura T et al. (2007a). PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. Cancer Res 67: 11924\u201311932.", "journal-title": "Cancer Res"}, {"key": "BFonc2009526_CR12", "doi-asserted-by": "publisher", "first-page": "1039", "DOI": "10.1126/science.1141478", "volume": "316", "author": "JA Engelman", "year": "2007", "unstructured": "Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO et al. (2007b). MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316: 1039\u20131043.", "journal-title": "Science"}, {"key": "BFonc2009526_CR13", "doi-asserted-by": "publisher", "first-page": "500", "DOI": "10.1182/blood-2006-05-025049", "volume": "109", "author": "FJ Giles", "year": "2007", "unstructured": "Giles FJ, Cortes J, Jones D, Bergstrom D, Kantarjian H, Freedman SJ . (2007). MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation. Blood 109: 500\u2013502.", "journal-title": "Blood"}, {"key": "BFonc2009526_CR14", "doi-asserted-by": "publisher", "first-page": "7319", "DOI": "10.1158/0008-5472.CAN-06-4625", "volume": "67", "author": "N Godin-Heymann", "year": "2007", "unstructured": "Godin-Heymann N, Bryant I, Rivera MN, Ulkus L, Bell DW, Riese 2nd DJ et al. (2007). Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation. Cancer Res 67: 7319\u20137326.", "journal-title": "Cancer Res"}, {"key": "BFonc2009526_CR15", "doi-asserted-by": "publisher", "first-page": "876", "DOI": "10.1126/science.1062538", "volume": "293", "author": "ME Gorre", "year": "2001", "unstructured": "Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. (2001). Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293: 876\u2013880.", "journal-title": "Science"}, {"key": "BFonc2009526_CR16", "doi-asserted-by": "publisher", "first-page": "4874", "DOI": "10.1158/1078-0432.CCR-07-0484", "volume": "13", "author": "T Guo", "year": "2007", "unstructured": "Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG et al. (2007). Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer Res 13: 4874\u20134881.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2009526_CR17", "doi-asserted-by": "publisher", "first-page": "3340", "DOI": "10.1200/JCO.2005.05.4692", "volume": "24", "author": "A Inoue", "year": "2006", "unstructured": "Inoue A, Suzuki T, Fukuhara T, Maemondo M, Kimura Y, Morikawa N et al. (2006). Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations. J Clin Oncol 24: 3340\u20133346.", "journal-title": "J Clin Oncol"}, {"issue": "15_suppl", "key": "BFonc2009526_CR18", "doi-asserted-by": "publisher", "first-page": "8027", "DOI": "10.1200/jco.2008.26.15_suppl.8027", "volume": "26", "author": "P. A. Janne", "year": "2008", "unstructured": "Janne PA, Schellens JH, Engelman JA, Eckhardt SG, Milham R, Denis LJ et al. (2008). Preliminary activity and safety results from a phase I clinical trial of PF-00299804, an irreversible pan-HER inhibitor, in patients (pts) with NSCLC. J Clin Oncol 26(Suppl): abstract 8027.", "journal-title": "Journal of Clinical Oncology"}, {"key": "BFonc2009526_CR19", "doi-asserted-by": "publisher", "first-page": "645", "DOI": "10.1056/NEJMoa011573", "volume": "346", "author": "H Kantarjian", "year": "2002", "unstructured": "Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C et al. (2002). Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346: 645\u2013652.", "journal-title": "N Engl J Med"}, {"key": "BFonc2009526_CR20", "doi-asserted-by": "publisher", "first-page": "1069", "DOI": "10.1128/MCB.1.12.1069", "volume": "1", "author": "RJ Kaufman", "year": "1981", "unstructured": "Kaufman RJ, Schimke RT . (1981). Amplification and loss of dihydrofolate reductase genes in a Chinese hamster ovary cell line. Mol Cell Biol 1: 1069\u20131076.", "journal-title": "Mol Cell Biol"}, {"key": "BFonc2009526_CR21", "doi-asserted-by": "publisher", "first-page": "786", "DOI": "10.1056/NEJMoa044238", "volume": "352", "author": "S Kobayashi", "year": "2005", "unstructured": "Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, Meyerson M et al. (2005). EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352: 786\u2013792.", "journal-title": "N Engl J Med"}, {"key": "BFonc2009526_CR22", "doi-asserted-by": "publisher", "first-page": "5764", "DOI": "10.1158/1078-0432.CCR-06-0714", "volume": "12", "author": "T Kosaka", "year": "2006", "unstructured": "Kosaka T, Yatabe Y, Endoh H, Yoshida K, Hida T, Tsuboi M et al. (2006). Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clin Cancer Res 12: 5764\u20135769.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2009526_CR23", "doi-asserted-by": "publisher", "first-page": "7665", "DOI": "10.1073/pnas.0502860102", "volume": "102", "author": "EL Kwak", "year": "2005", "unstructured": "Kwak EL, Sordella R, Bell DW, Godin-Heymann N, Okimoto RA, Brannigan BW et al. (2005). Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci USA 102: 7665\u20137670.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2009526_CR24", "doi-asserted-by": "publisher", "first-page": "4702", "DOI": "10.1038/onc.2008.109", "volume": "27", "author": "D Li", "year": "2008", "unstructured": "Li D, Ambrogio L, Shimamura T, Kubo S, Takahashi M, Chirieac LR et al. (2008). BIBW2992 an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene 27: 4702\u20134711.", "journal-title": "Oncogene"}, {"key": "BFonc2009526_CR25", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1056/NEJMoa0800668", "volume": "359", "author": "S Maheswaran", "year": "2008", "unstructured": "Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV et al. (2008). Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366\u2013377.", "journal-title": "N Engl J Med"}, {"key": "BFonc2009526_CR26", "doi-asserted-by": "publisher", "first-page": "947", "DOI": "10.1056/NEJMoa0810699", "volume": "361", "author": "TS Mok", "year": "2009", "unstructured": "Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N et al. (2009). Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361: 947\u2013957.", "journal-title": "N Engl J Med"}, {"key": "BFonc2009526_CR27", "doi-asserted-by": "publisher", "first-page": "1185", "DOI": "10.1093/jnci/dji238", "volume": "97", "author": "T Mukohara", "year": "2005", "unstructured": "Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N et al. (2005). Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. J Natl Cancer Inst 97: 1185\u20131194.", "journal-title": "J Natl Cancer Inst"}, {"key": "BFonc2009526_CR28", "first-page": "465", "volume": "3", "author": "M Ono", "year": "2004", "unstructured": "Ono M, Hirata A, Kometani T, Miyagawa M, Ueda S, Kinoshita H et al. (2004). Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Mol Cancer Ther 3: 465\u2013472.", "journal-title": "Mol Cancer Ther"}, {"key": "BFonc2009526_CR29", "doi-asserted-by": "publisher", "first-page": "1497", "DOI": "10.1126/science.1099314", "volume": "304", "author": "JG Paez", "year": "2004", "unstructured": "Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S et al. (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497\u20131500.", "journal-title": "Science"}, {"key": "BFonc2009526_CR30", "doi-asserted-by": "publisher", "first-page": "4392", "DOI": "10.1158/1078-0432.CCR-08-0117", "volume": "14", "author": "A Quintas-Cardama", "year": "2008", "unstructured": "Quintas-Cardama A, Cortes J . (2008). Therapeutic options against BCR-ABL1T315I positive chronic myelogenous leukemia. Clin Cancer Res 14: 4392\u20134399.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2009526_CR31", "doi-asserted-by": "publisher", "first-page": "12480", "DOI": "10.1073/pnas.0803217105", "volume": "105", "author": "SM Rothenberg", "year": "2008", "unstructured": "Rothenberg SM, Engelman JA, Le S, Riese 2nd DJ, Haber DA, Settleman J . (2008). Modeling oncogene addiction using RNA interference. Proc Natl Acad Sci USA 105: 12480\u201312484.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2009526_CR32", "doi-asserted-by": "publisher", "first-page": "589", "DOI": "10.1158/0008-5472.CAN-07-1570", "volume": "68", "author": "A Sawai", "year": "2008", "unstructured": "Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL et al. (2008). Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Cancer Res 68: 589\u2013596.", "journal-title": "Cancer Res"}, {"issue": "Suppl", "key": "BFonc2009526_CR33", "first-page": "3599", "volume": "25", "author": "JH Schellens", "year": "2007", "unstructured": "Schellens JH, Britten CD, camidge DR, D Boss, Wong S, Diab S et al. (2007). First-in-human study of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-00299804, a small molecule irreversible pan-HER inhibitor in patients with advanced cancer. J Clin Oncol, 2007 ASCO Annu Meet Proc Part I 25(Suppl): 3599.", "journal-title": "J Clin Oncol, 2007 ASCO Annu Meet Proc Part I"}, {"key": "BFonc2009526_CR34", "doi-asserted-by": "publisher", "first-page": "1051", "DOI": "10.1126/science.715457", "volume": "202", "author": "RT Schimke", "year": "1978", "unstructured": "Schimke RT, Kaufman RJ, Alt FW, Kellems RF . (1978). Gene amplification and drug resistance in cultured murine cells. Science 202: 1051\u20131055.", "journal-title": "Science"}, {"key": "BFonc2009526_CR35", "doi-asserted-by": "publisher", "first-page": "2442", "DOI": "10.1200/JCO.2007.14.8494", "volume": "26", "author": "LV Sequist", "year": "2008", "unstructured": "Sequist LV, Martins RG, Spigel D, Grunberg SM, Spira A, Janne PA et al. (2008). First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol 26: 2442\u20132449.", "journal-title": "J Clin Oncol"}, {"key": "BFonc2009526_CR36", "doi-asserted-by": "publisher", "first-page": "485", "DOI": "10.1016/j.ccr.2008.11.001", "volume": "14", "author": "NP Shah", "year": "2008", "unstructured": "Shah NP, Kasap C, Weier C, Balbas M, Nicoll JM, Bleickardt E et al. (2008). Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis. Cancer Cell 14: 485\u2013493.", "journal-title": "Cancer Cell"}, {"key": "BFonc2009526_CR37", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/S1535-6108(02)00096-X", "volume": "2", "author": "NP Shah", "year": "2002", "unstructured": "Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J et al. (2002). Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2: 117\u2013125.", "journal-title": "Cancer Cell"}, {"key": "BFonc2009526_CR38", "doi-asserted-by": "publisher", "first-page": "5827", "DOI": "10.1158/0008-5472.CAN-07-5428", "volume": "68", "author": "T Shimamura", "year": "2008", "unstructured": "Shimamura T, Li D, Ji H, Haringsma HJ, Liniker E, Borgman CL et al. (2008). Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance. Cancer Res 68: 5827\u20135838.", "journal-title": "Cancer Res"}, {"key": "BFonc2009526_CR39", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1053/j.gastro.2004.02.021", "volume": "127", "author": "E Tamborini", "year": "2004", "unstructured": "Tamborini E, Bonadiman L, Greco A, Albertini V, Negri T, Gronchi A et al. (2004). A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. Gastroenterology 127: 294\u2013299.", "journal-title": "Gastroenterology"}, {"key": "BFonc2009526_CR40", "doi-asserted-by": "publisher", "first-page": "4665", "DOI": "10.1158/0008-5472.CAN-07-0217", "volume": "67", "author": "H Vikis", "year": "2007", "unstructured": "Vikis H, Sato M, James M, Wang D, Wang Y, Wang M et al. (2007). EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 67: 4665\u20134670.", "journal-title": "Cancer Res"}, {"key": "BFonc2009526_CR41", "doi-asserted-by": "publisher", "first-page": "2552", "DOI": "10.1158/1078-0432.CCR-08-1978", "volume": "15", "author": "KK Wong", "year": "2009", "unstructured": "Wong KK, Fracasso PM, Bukowski RM, Lynch TJ, Munster PN, Shapiro GI et al. (2009). A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors. Clin Cancer Res 15: 2552\u20132558.", "journal-title": "Clin Cancer Res"}, {"key": "BFonc2009526_CR42", "doi-asserted-by": "publisher", "first-page": "2070", "DOI": "10.1073/pnas.0709662105", "volume": "105", "author": "CH Yun", "year": "2008", "unstructured": "Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK et al. (2008). The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci USA 105: 2070\u20132075.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFonc2009526_CR43", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.4161/cbt.6.5.4003", "volume": "6", "author": "Y Yuza", "year": "2007", "unstructured": "Yuza Y, Glatt KA, Jiang J, Greulich H, Minami Y, Woo MS et al. (2007). Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors. Cancer Biol Ther 6: 661\u2013667.", "journal-title": "Cancer Biol Ther"}, {"key": "BFonc2009526_CR44", "doi-asserted-by": "publisher", "first-page": "5561", "DOI": "10.1158/0008-5472.CAN-04-4603", "volume": "65", "author": "X Zhao", "year": "2005", "unstructured": "Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L et al. (2005). Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65: 5561\u20135570.", "journal-title": "Cancer Res"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/onc2009526.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2009526", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/onc2009526.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T19:06:30Z", "timestamp": 1555614390000}, "score": 24.844398, "issued": {"date-parts": [[2010, 2, 1]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2010, 4]]}, "issue": "16"}, "alternative-id": ["BFonc2009526"], "URL": "http://dx.doi.org/10.1038/onc.2009.526", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T08:21:12Z", "timestamp": 1575534072156}, "reference-count": 42, "publisher": "Royal Society of Chemistry (RSC)", "issue": "42", "license": [{"URL": "http://rsc.li/journals-terms-of-use", "start": {"date-parts": [[2020, 10, 18]], "date-time": "2020-10-18T00:00:00Z", "timestamp": 1602979200000}, "delay-in-days": 656, "content-version": "am"}], "funder": [{"DOI": "10.13039/501100000265", "name": "Medical Research Council", "doi-asserted-by": "publisher", "award": ["MC_PC_15013", "MRC grant 1598124"]}, {"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "publisher", "award": ["R01CA198096", "R21CA168454"]}], "content-domain": {"domain": ["rsc.org"], "crossmark-restriction": true}, "short-container-title": ["Nanoscale"], "abstract": "<p>The use of CTX as a targeting agent for camptothecin-loaded polymeric nanoparticles directed against KRAS mutant CTX-resistant cancer cells was investigated. CTX increased CPT internalisation into cancer cells resulting in elevated cancer cell death.</p>", "DOI": "10.1039/c9nr07257h", "type": "journal-article", "created": {"date-parts": [[2019, 10, 18]], "date-time": "2019-10-18T13:49:29Z", "timestamp": 1571406569000}, "page": "20261-20273", "update-policy": "http://dx.doi.org/10.1039/rsc_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours"], "prefix": "10.1039", "volume": "11", "author": [{"given": "William J.", "family": "McDaid", "sequence": "first", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Michelle K.", "family": "Greene", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Michael C.", "family": "Johnston", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Ellen", "family": "Pollheimer", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Peter", "family": "Smyth", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Kirsty", "family": "McLaughlin", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Sandra", "family": "Van Schaeybroeck", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"given": "Robert M.", "family": "Straubinger", "sequence": "additional", "affiliation": [{"name": "Department of Pharmaceutical Sciences"}, {"name": "University at Buffalo"}, {"name": "State University of New York"}, {"name": "Amherst"}, {"name": "USA"}]}, {"given": "Daniel B.", "family": "Longley", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}, {"ORCID": "http://orcid.org/0000-0002-7582-3808", "authenticated-orcid": false, "given": "Christopher J.", "family": "Scott", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Research and Cell Biology"}, {"name": "Queen's University Belfast"}, {"name": "Belfast"}, {"name": "UK"}]}], "member": "292", "published-online": {"date-parts": [[2019]]}, "reference": [{"key": "C9NR07257H-(cit1)/*[position()=1]", "author": "Brand", "volume": "11", "first-page": "777", "year": "2011", "journal-title": "Cancer Biol. Ther.", "DOI": "10.4161/cbt.11.9.15050", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit2)/*[position()=1]", "author": "Normanno", "volume": "366", "first-page": "2", "year": "2006", "journal-title": "Gene", "DOI": "10.1016/j.gene.2005.10.018", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit3)/*[position()=1]", "author": "Masui", "volume": "44", "first-page": "1002", "year": "1984", "journal-title": "Cancer Res."}, {"key": "C9NR07257H-(cit4)/*[position()=1]", "author": "Li", "volume": "7", "first-page": "301", "year": "2005", "journal-title": "Cancer Cell", "DOI": "10.1016/j.ccr.2005.03.003", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit5)/*[position()=1]", "author": "Di Nicolantonio", "volume": "26", "first-page": "5705", "year": "2008", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.2008.18.0786", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit6)/*[position()=1]", "author": "Li\u00e8vre", "volume": "66", "first-page": "3992", "year": "2006", "journal-title": "Cancer Res.", "DOI": "10.1158/0008-5472.CAN-06-0191", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit7)/*[position()=1]", "author": "Stintzing", "volume": "17", "first-page": "1426", "year": "2016", "journal-title": "Lancet Oncol.", "DOI": "10.1016/S1470-2045(16)30269-8", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit8)/*[position()=1]", "author": "Tan", "volume": "18", "first-page": "5171", "year": "2012", "journal-title": "World J. Gastroenterol.", "DOI": "10.3748/wjg.v18.i42.6127", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit9)/*[position()=1]", "author": "Rom\u00e1n", "volume": "17", "first-page": "1", "year": "2018", "journal-title": "Mol. Cancer", "DOI": "10.1186/s12943-018-0789-x", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit10)/*[position()=1]", "author": "Waddell", "volume": "518", "first-page": "495", "year": "2015", "journal-title": "Nature", "DOI": "10.1038/nature14169", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit11)/*[position()=1]", "author": "van Houdt", "volume": "12", "first-page": "443", "year": "2010", "journal-title": "Neoplasia", "DOI": "10.1593/neo.92088", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit12)/*[position()=1]", "author": "Misale", "volume": "486", "first-page": "532", "year": "2012", "journal-title": "Nature", "DOI": "10.1038/nature11156", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit13)/*[position()=1]", "author": "Reichert", "volume": "3", "first-page": "76", "year": "2011", "journal-title": "mAbs", "DOI": "10.4161/mabs.3.1.13895", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit14)/*[position()=1]", "author": "Krop", "volume": "30", "first-page": "3234", "year": "2012", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.2011.40.5902", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit15)/*[position()=1]", "author": "Mavilio", "volume": "2", "first-page": "5", "year": "2013", "journal-title": "OncoImmunology"}, {"key": "C9NR07257H-(cit16)/*[position()=1]", "author": "Fay", "volume": "3", "first-page": "381", "year": "2011", "journal-title": "Immunotherapy", "DOI": "10.2217/imt.11.5", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit17)/*[position()=1]", "author": "Johnston", "volume": "30", "first-page": "63", "year": "2018", "journal-title": "Drug Discovery Today: Technol.", "DOI": "10.1016/j.ddtec.2018.10.003", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit18)/*[position()=1]", "author": "Schmid", "volume": "22", "first-page": "2083", "year": "2014", "journal-title": "Mol. Ther.", "DOI": "10.1038/mt.2014.137", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit19)/*[position()=1]", "author": "Shirasawa", "volume": "260", "first-page": "85", "year": "1993", "journal-title": "Science", "DOI": "10.1126/science.8465203", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit20)/*[position()=1]", "author": "Schmid", "volume": "5", "first-page": "e1454", "year": "2014", "journal-title": "Cell Death Dis.", "DOI": "10.1038/cddis.2014.413", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit21)/*[position()=1]", "author": "Passero", "volume": "16", "first-page": "697", "year": "2016", "journal-title": "Expert Rev. Anticancer Ther.", "DOI": "10.1080/14737140.2016.1192471", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit22)/*[position()=1]", "author": "McCarron", "volume": "19", "first-page": "1561", "year": "2008", "journal-title": "Bioconjugate Chem.", "DOI": "10.1021/bc800057g", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit23)/*[position()=1]", "author": "Gradiz", "volume": "6", "first-page": "e21648", "year": "2016", "journal-title": "Sci. Rep.", "DOI": "10.1038/srep21648", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit24)/*[position()=1]", "author": "Ahmed", "volume": "2", "first-page": "e71", "year": "2013", "journal-title": "Oncogenesis", "DOI": "10.1038/oncsis.2013.35", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit25)/*[position()=1]", "author": "Singh", "volume": "15", "first-page": "489", "year": "2009", "journal-title": "Cancer Cell", "DOI": "10.1016/j.ccr.2009.03.022", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit26)/*[position()=1]", "author": "Deer", "volume": "39", "first-page": "425", "year": "2010", "journal-title": "Pancreas", "DOI": "10.1097/MPA.0b013e3181c15963", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit27)/*[position()=1]", "author": "Toda", "volume": "18", "first-page": "654", "year": "2016", "journal-title": "Neoplasia", "DOI": "10.1016/j.neo.2016.09.004", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit28)/*[position()=1]", "author": "Chakrabarti", "volume": "16", "first-page": "e145", "year": "2015", "journal-title": "Radiat. Oncol.", "DOI": "10.1186/s13014-015-0457-x", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit29)/*[position()=1]", "author": "Kim", "volume": "36", "first-page": "2543", "year": "2017", "journal-title": "Oncogene", "DOI": "10.1038/onc.2016.407", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit30)/*[position()=1]", "author": "Waters", "volume": "8", "first-page": "a031435", "year": "2018", "journal-title": "Cold Spring Harbor Perspect. Med.", "DOI": "10.1101/cshperspect.a031435", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit31)/*[position()=1]", "author": "Huang", "volume": "111", "first-page": "274", "year": "2003", "journal-title": "J. Surg. Res.", "DOI": "10.1016/S0022-4804(03)00076-3", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit32)/*[position()=1]", "author": "De Miguel", "volume": "39", "first-page": "657", "year": "2015", "journal-title": "Leuk. Res.", "DOI": "10.1016/j.leukres.2015.03.019", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit33)/*[position()=1]", "author": "Qian", "volume": "4", "first-page": "1", "year": "2014", "journal-title": "Sci. Rep."}, {"key": "C9NR07257H-(cit34)/*[position()=1]", "author": "Pizzolato", "volume": "361", "first-page": "2235", "year": "2003", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(03)13780-4", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit35)/*[position()=1]", "author": "Pommier", "volume": "6", "first-page": "789", "year": "2006", "journal-title": "Nat. Rev. Cancer", "DOI": "10.1038/nrc1977", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit36)/*[position()=1]", "author": "Slatter", "year": "2000", "journal-title": "Drug Metab. Dispos."}, {"key": "C9NR07257H-(cit37)/*[position()=1]", "author": "Anthony", "year": "2007", "journal-title": "Curr. Opin. Supportive Palliative Care"}, {"key": "C9NR07257H-(cit38)/*[position()=1]", "author": "Weiss", "volume": "31", "first-page": "986", "year": "2013", "journal-title": "Invest. New Drugs", "DOI": "10.1007/s10637-012-9921-8", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit39)/*[position()=1]", "author": "Patra", "volume": "68", "first-page": "1970", "year": "2008", "journal-title": "Cancer Res.", "DOI": "10.1158/0008-5472.CAN-07-6102", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit40)/*[position()=1]", "author": "Sreeranganathan", "volume": "12", "first-page": "7165", "year": "2017", "journal-title": "Int. J. Nanomed.", "DOI": "10.2147/IJN.S143529", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit41)/*[position()=1]", "author": "Limasale", "volume": "479", "first-page": "364", "year": "2015", "journal-title": "Int. J. Pharm.", "DOI": "10.1016/j.ijpharm.2015.01.016", "doi-asserted-by": "crossref"}, {"key": "C9NR07257H-(cit42)/*[position()=1]", "author": "Deepagan", "volume": "7", "first-page": "507", "year": "2012", "journal-title": "Nanomedicine", "DOI": "10.2217/nnm.11.139", "doi-asserted-by": "crossref"}], "container-title": ["Nanoscale"], "language": "en", "link": [{"URL": "http://pubs.rsc.org/en/content/articlepdf/2019/NR/C9NR07257H", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 1]], "date-time": "2019-11-01T13:05:12Z", "timestamp": 1572613512000}, "score": 24.421719, "issued": {"date-parts": [[2019]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2019, 10, 31]]}, "issue": "42"}, "URL": "http://dx.doi.org/10.1039/c9nr07257h", "relation": {"cites": []}, "ISSN": ["2040-3364", "2040-3372"], "issn-type": [{"value": "2040-3364", "type": "print"}, {"value": "2040-3372", "type": "electronic"}], "subject": ["General Materials Science"], "assertion": [{"value": "This document is Similarity Check deposited", "name": "similarity_check", "explanation": {"URL": "https://www.crossref.org/services/similarity-check/"}, "group": {"name": "similarity_check", "label": "SIMILARITY CHECK"}}, {"value": "Supplementary Information", "URL": "https://doi.org/10.1039/C9NR07257H", "name": "related_data", "group": {"name": "related_data", "label": "RELATED DATA"}}, {"value": "Christopher J. Scott (ORCID)", "URL": "http://orcid.org/0000-0002-7582-3808", "name": "identifier", "group": {"name": "author_identifiers", "label": "IDENTIFIERS"}}, {"value": "Single-blind", "order": 2, "name": "peer_review_method", "group": {"name": "peer_review_method", "label": "PEER REVIEW METHOD"}}, {"value": "Received 22 August 2019; Accepted 22 September 2019;  Advance Article published 18 October 2019;  Version of Record published 31 October 2019", "order": 1, "name": "history", "group": {"name": "publication_history", "label": "PUBLICATION HISTORY"}}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T05:34:54Z", "timestamp": 1574746494693}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 2, 1]], "date-time": "2017-02-01T00:00:00Z", "timestamp": 1485907200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[2017, 2]]}, "DOI": "10.1016/s0959-8049(17)30427-6", "type": "journal-article", "created": {"date-parts": [[2017, 2, 7]], "date-time": "2017-02-07T04:20:16Z", "timestamp": 1486441216000}, "page": "S105-S106", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Concurrent chemoradiation (CCRT) or radiotherapy with anti-EGFR directed monoclonal antibody (anti-EGFR) or CCRT + anti-EGFR in locoregionally advanced head-and-neck squamous cell carcinoma (LA-HNSCC): a comprehensive review of randomized data"], "prefix": "10.1016", "volume": "72", "author": [{"given": "P.", "family": "Specenier", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "Janssens", "sequence": "additional", "affiliation": []}, {"given": "J.B.", "family": "Vermorken", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804917304276?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804917304276?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 4]], "date-time": "2018-09-04T13:54:25Z", "timestamp": 1536069265000}, "score": 24.118937, "issued": {"date-parts": [[2017, 2]]}, "references-count": 0, "alternative-id": ["S0959804917304276"], "URL": "http://dx.doi.org/10.1016/s0959-8049(17)30427-6", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:06:38Z", "timestamp": 1574690798297}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2014, 10, 1]]}, "DOI": "10.1158/1538-7445.am2014-1844", "type": "proceedings-article", "created": {"date-parts": [[2015, 5, 4]], "date-time": "2015-05-04T19:01:12Z", "timestamp": 1430766072000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 1844: Novel HER3 neutralizing antibody, patritumab abrogates cetuximab resistance mediated by a heregulin-autocrine loop in colorectal cancer"], "prefix": "10.1158", "author": [{"given": "Hisato", "family": "Kawakami", "sequence": "first", "affiliation": []}, {"given": "Isamu", "family": "Okamoto", "sequence": "additional", "affiliation": []}, {"given": "Kimio", "family": "Yonesaka", "sequence": "additional", "affiliation": []}, {"given": "Kunio", "family": "Okamoto", "sequence": "additional", "affiliation": []}, {"given": "Kiyoko", "family": "Kuwata", "sequence": "additional", "affiliation": []}, {"given": "Yume", "family": "Morita", "sequence": "additional", "affiliation": []}, {"given": "Haruka", "family": "Yamaguchi", "sequence": "additional", "affiliation": []}, {"given": "Kazuto", "family": "Nishio", "sequence": "additional", "affiliation": []}, {"given": "Kazuhiko", "family": "Nakagawa", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 9, 30]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA"}, "container-title": ["Experimental and Molecular Therapeutics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2014-1844", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T15:30:35Z", "timestamp": 1558193435000}, "score": 23.64717, "issued": {"date-parts": [[2014, 9, 30]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2014-1844"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2014-1844"}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T08:33:33Z", "timestamp": 1575534813417}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 10, 1]], "date-time": "2019-10-01T00:00:00Z", "timestamp": 1569888000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["jto.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Thoracic Oncology"], "published-print": {"date-parts": [[2019, 10]]}, "DOI": "10.1016/j.jtho.2019.08.1800", "type": "journal-article", "created": {"date-parts": [[2019, 10, 21]], "date-time": "2019-10-21T09:28:56Z", "timestamp": 1571650136000}, "page": "S835", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P2.14-15 Impact of Coexisting Gene Mutations in EGFR-Mutated Non\u2013Small Cell Lung Cancer Before Treatment on EGFR T790M Mutation Status After EGFR-TKIs"], "prefix": "10.1016", "volume": "14", "author": [{"given": "M.", "family": "Takeda", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "Sakai", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Hayashi", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Tanaka", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Haratani", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Takahama", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Kato", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Yonesaka", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nishio", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nakagawa", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Thoracic Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1556086419324839?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1556086419324839?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 11, 8]], "date-time": "2019-11-08T23:45:13Z", "timestamp": 1573256713000}, "score": 23.534515, "issued": {"date-parts": [[2019, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 10]]}, "issue": "10"}, "alternative-id": ["S1556086419324839"], "URL": "http://dx.doi.org/10.1016/j.jtho.2019.08.1800", "ISSN": ["1556-0864"], "issn-type": [{"value": "1556-0864", "type": "print"}], "subject": ["Oncology", "Pulmonary and Respiratory Medicine"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "P2.14-15 Impact of Coexisting Gene Mutations in EGFR-Mutated Non\u2013Small Cell Lung Cancer Before Treatment on EGFR T790M Mutation Status After EGFR-TKIs", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Thoracic Oncology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jtho.2019.08.1800", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2019 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:44:03Z", "timestamp": 1574509443373}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 12, 15]]}, "DOI": "10.1158/0008-5472.sabcs10-p6-14-17", "type": "proceedings-article", "created": {"date-parts": [[2011, 4, 27]], "date-time": "2011-04-27T13:50:42Z", "timestamp": 1303912242000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract P6-14-17:In VitroEvaluation of the Anti-EGFR Antibody Cetuximab and the Anti-HER2 Antibody Trastuzumab in a Panel of Human Tumor Cell Lines"], "prefix": "10.1158", "author": [{"given": "KF", "family": "Marcoe", "sequence": "first", "affiliation": []}, {"given": "Y", "family": "Ovechkina", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Keyser", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Bernards", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Chestnut-Speelman", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Yoshino", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "O'Day", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 6]]}, "event": {"name": "Abstracts: Thirty-Third Annual CTRC\u2010AACR San Antonio Breast Cancer Symposium\u2010\u2010 Dec 8\u201012, 2010; San Antonio, TX"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.SABCS10-P6-14-17", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T16:59:14Z", "timestamp": 1558198754000}, "score": 23.375546, "issued": {"date-parts": [[2010, 12, 15]]}, "references-count": 0, "alternative-id": ["10.1158/0008-5472.SABCS10-P6-14-17"], "URL": "http://dx.doi.org/10.1158/0008-5472.sabcs10-p6-14-17"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:48:48Z", "timestamp": 1574538528768}, "publisher-location": "Weinheim, Germany", "reference-count": 72, "publisher": "Wiley-VCH Verlag GmbH & Co. KGaA", "isbn-type": [{"value": "9783527329373", "type": "print"}, {"value": "9783527682423", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9783527682423.ch18", "type": "book-chapter", "created": {"date-parts": [[2014, 8, 12]], "date-time": "2014-08-12T13:41:04Z", "timestamp": 1407850864000}, "page": "475-486", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Antibody-Directed Enzyme Prodrug Therapy (ADEPT)"], "prefix": "10.1002", "author": [{"given": "Surinder K.", "family": "Sharma", "sequence": "first", "affiliation": []}, {"given": "Kerry A.", "family": "Chester", "sequence": "additional", "affiliation": []}, {"given": "Kenneth D.", "family": "Bagshawe", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2014, 8, 12]]}, "reference": [{"issue": "3", "key": "10.1002/9783527682423.ch18-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1084/jem.122.3.467", "article-title": "Specific carcinoembryonic antigens of the human digestive system", "volume": "122", "author": "Gold", "year": "1965", "journal-title": "J. Exp. Med."}, {"issue": "450", "key": "10.1002/9783527682423.ch18-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1038/248704a0", "article-title": "In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice", "volume": "248", "author": "Mach", "year": "1974", "journal-title": "Nature"}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB3|cit3", "first-page": "1", "article-title": "Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G", "volume": "34", "author": "Goldenberg", "year": "1974", "journal-title": "Cancer Res."}, {"issue": "5517", "key": "10.1002/9783527682423.ch18-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1038/256495a0", "article-title": "Continuous cultures of fused cells secreting antibody of predefined specificity", "volume": "256", "author": "Kohler", "year": "1975", "journal-title": "Nature"}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB5|cit5", "first-page": "1175", "article-title": "The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities", "volume": "35", "author": "Hurwitz", "year": "1975", "journal-title": "Cancer Res."}, {"issue": "5647", "key": "10.1002/9783527682423.ch18-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "752", "DOI": "10.1038/271752a0", "article-title": "Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin", "volume": "271", "author": "Thorpe", "year": "1978", "journal-title": "Nature"}, {"issue": "7", "key": "10.1002/9783527682423.ch18-BIB7|cit7", "first-page": "1089", "article-title": "Immunotoxins in cancer therapy", "volume": "3", "author": "Pastan", "year": "2002", "journal-title": "Curr. Opin. Investig. Drugs"}, {"issue": "4", "key": "10.1002/9783527682423.ch18-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1038/nrd3980", "article-title": "Antibody-drug conjugates", "volume": "12", "author": "Zolot", "year": "2013", "journal-title": "Nat. Rev. Drug Discovery"}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1038/bjc.1993.288", "article-title": "Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model", "volume": "68", "author": "Pedley", "year": "1993", "journal-title": "Br. J. Cancer"}, {"key": "10.1002/9783527682423.ch18-BIB10|cit10", "first-page": "321", "article-title": "Antigenic heterogeneity of breast cell lines detected by monoclonal antibodies and its relationship with the cell cycle", "volume": "73", "author": "Edwards", "year": "1985", "journal-title": "J. Cell Sci."}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1038/bjc.1987.237", "article-title": "Antibody directed enzymes revive anti-cancer prodrugs concept", "volume": "56", "author": "Bagshawe", "year": "1987", "journal-title": "Br. J. Cancer"}, {"issue": "6", "key": "10.1002/9783527682423.ch18-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1038/bjc.1988.293", "article-title": "A cytotoxic agent can be generated selectively at cancer sites", "volume": "58", "author": "Bagshawe", "year": "1988", "journal-title": "Br. J. Cancer"}, {"issue": "13", "key": "10.1002/9783527682423.ch18-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "4842", "DOI": "10.1073/pnas.85.13.4842", "article-title": "Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate", "volume": "85", "author": "Senter", "year": "1988", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.2165/00003088-199528020-00004", "article-title": "Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions", "volume": "28", "author": "Reilly", "year": "1995", "journal-title": "Clin. Pharmacokinet."}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/0165-6147(93)90197-R", "article-title": "Humanized antibodies", "volume": "14", "author": "Winter", "year": "1993", "journal-title": "Trends Pharmacol. Sci."}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1111/j.1432-1033.1985.tb08860.x", "article-title": "Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method", "volume": "148", "author": "Sherwood", "year": "1985", "journal-title": "Eur. J. Biochem."}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1038/bjc.1989.270", "article-title": "The first Bagshawe lecture. Towards generating cytotoxic agents at cancer sites", "volume": "60", "author": "Bagshawe", "year": "1989", "journal-title": "Br. J. Cancer"}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1038/bjc.1986.62", "article-title": "The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro", "volume": "53", "author": "Searle", "year": "1986", "journal-title": "Br. J. Cancer"}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1002/bjs.1800730126", "article-title": "Radioimmunolocalization and selection for surgery in recurrent colorectal cancer", "volume": "73", "author": "Begent", "year": "1986", "journal-title": "Br. J. Surg."}, {"issue": "11", "key": "10.1002/9783527682423.ch18-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1016/0277-5379(91)90010-B", "article-title": "Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds", "volume": "27", "author": "Springer", "year": "1991", "journal-title": "Eur. J. Cancer"}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1021/jm00164a034", "article-title": "Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2", "volume": "33", "author": "Springer", "year": "1990", "journal-title": "J. Med. Chem."}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1038/bjc.1990.149", "article-title": "Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model", "volume": "61", "author": "Sharma", "year": "1990", "journal-title": "Br. J. Cancer"}, {"issue": "3-4", "key": "10.1002/9783527682423.ch18-BIB23|cit23", "first-page": "225", "article-title": "Antibody directed enzyme prodrug therapy (ADEPT): a three phase system", "volume": "9", "author": "Sharma", "year": "1991", "journal-title": "Dis. Markers"}, {"key": "10.1002/9783527682423.ch18-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1007/BF02789232", "article-title": "Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenografts", "volume": "24-25", "author": "Sharma", "year": "1994", "journal-title": "Cell Biophys."}, {"issue": "19", "key": "10.1002/9783527682423.ch18-BIB25|cit25", "first-page": "5171", "article-title": "Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185", "volume": "54", "author": "Eccles", "year": "1994", "journal-title": "Cancer Res."}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1016/S0169-409X(01)00206-X", "article-title": "Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates", "volume": "53", "author": "Senter", "year": "2001", "journal-title": "Adv. Drug Deliv. Rev."}, {"issue": "11", "key": "10.1002/9783527682423.ch18-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "1777", "DOI": "10.1517/14712598.4.11.1777", "article-title": "Antibody-directed enzyme prodrug therapy (ADEPT) for cancer", "volume": "4", "author": "Bagshawe", "year": "2004", "journal-title": "Expert Opin. Biol. Ther."}, {"issue": "8", "key": "10.1002/9783527682423.ch18-BIB28|cit28", "first-page": "2151", "article-title": "Tumor-selective prodrug activation by fusion protein-mediated catalysis", "volume": "54", "author": "Bosslet", "year": "1994", "journal-title": "Cancer Res."}, {"issue": "25", "key": "10.1002/9783527682423.ch18-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "15804", "DOI": "10.1074/jbc.272.25.15804", "article-title": "Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate", "volume": "272", "author": "Smith", "year": "1997", "journal-title": "J. Biol. Chem."}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1038/bjc.1992.47", "article-title": "Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation", "volume": "65", "author": "Bosslet", "year": "1992", "journal-title": "Br. J. Cancer"}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "606", "DOI": "10.1021/bc960055j", "article-title": "Improved characteristics of a human beta-glucuronidase-antibody conjugate after deglycosylation for use in antibody-directed enzyme prodrug therapy", "volume": "7", "author": "Houba", "year": "1996", "journal-title": "Bioconjugate Chem."}, {"issue": "21", "key": "10.1002/9783527682423.ch18-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "3452", "DOI": "10.1021/jm00047a002", "article-title": "Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme", "volume": "37", "author": "Mauger", "year": "1994", "journal-title": "J. Med. Chem."}, {"issue": "16", "key": "10.1002/9783527682423.ch18-BIB33|cit33", "first-page": "3558", "article-title": "Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs", "volume": "55", "author": "Kerr", "year": "1995", "journal-title": "Cancer Res."}, {"issue": "10", "key": "10.1002/9783527682423.ch18-BIB34|cit34", "first-page": "2719", "article-title": "Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine", "volume": "54", "author": "Wallace", "year": "1994", "journal-title": "Cancer Res."}, {"issue": "7", "key": "10.1002/9783527682423.ch18-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1016/0041-0101(92)90003-N", "article-title": "Monoclonal antibody-based enzyme-linked immunoassays for the measurement of palytoxin in biological samples", "volume": "30", "author": "Bignami", "year": "1992", "journal-title": "Toxicon"}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1111/j.1582-4934.2003.tb00227.x", "article-title": "Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases", "volume": "7", "author": "Nevinsky", "year": "2003", "journal-title": "J. Cell. Mol. Med."}, {"issue": "20", "key": "10.1002/9783527682423.ch18-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "5247", "DOI": "10.1016/j.bmc.2004.03.077", "article-title": "Catalytic antibodies: hapten design strategies and screening methods", "volume": "12", "author": "Xu", "year": "2004", "journal-title": "Bioorg. Med. Chem."}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1073/pnas.93.2.799", "article-title": "Toward antibody-directed \u201cabzyme\u201d prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing", "volume": "93", "author": "Wentworth", "year": "1996", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"issue": "12", "key": "10.1002/9783527682423.ch18-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "6925", "DOI": "10.1073/pnas.96.12.6925", "article-title": "Multiple event activation of a generic prodrug trigger by antibody catalysis", "volume": "96", "author": "Shabat", "year": "1999", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"issue": "4", "key": "10.1002/9783527682423.ch18-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1016/S0022-2836(03)00992-6", "article-title": "A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy", "volume": "332", "author": "Rader", "year": "2003", "journal-title": "J. Mol. Biol."}, {"issue": "1-2", "key": "10.1002/9783527682423.ch18-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/S0022-1759(02)00241-7", "article-title": "Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy", "volume": "269", "author": "Kakinuma", "year": "2002", "journal-title": "J. Immunol. Methods"}, {"issue": "6", "key": "10.1002/9783527682423.ch18-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1038/nbt828", "article-title": "Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library", "volume": "21", "author": "Cesaro-Tadic", "year": "2003", "journal-title": "Nat. Biotechnol."}, {"issue": "9", "key": "10.1002/9783527682423.ch18-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1016/S0167-7799(03)00194-X", "article-title": "Phage display as a tool for the directed evolution of enzymes", "volume": "21", "author": "Fernandez-Gacio", "year": "2003", "journal-title": "Trends Biotechnol."}, {"issue": "3-4", "key": "10.1002/9783527682423.ch18-BIB44|cit44", "first-page": "233", "article-title": "Antibody directed enzyme prodrug therapy (ADEPT): clinical report", "volume": "9", "author": "Bagshawe", "year": "1991", "journal-title": "Dis. Markers"}, {"issue": "9", "key": "10.1002/9783527682423.ch18-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1016/S1357-4310(95)90815-3", "article-title": "Antibody-directed enzyme prodrug therapy for cancer: its theoretical basis and application", "volume": "1", "author": "Bagshawe", "year": "1995", "journal-title": "Mol. Med. Today"}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.2174/138945009787354520", "article-title": "Targeting: the ADEPT story so far", "volume": "10", "author": "Bagshawe", "year": "2009", "journal-title": "Curr. Drug Targets"}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB47|cit47", "first-page": "765", "article-title": "Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma", "volume": "6", "author": "Napier", "year": "2000", "journal-title": "Clin. Cancer Res."}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1007/s002800050646", "article-title": "Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial", "volume": "40", "author": "Martin", "year": "1997", "journal-title": "Cancer Chemother. Pharmacol."}, {"issue": "26", "key": "10.1002/9783527682423.ch18-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "5051", "DOI": "10.1021/jm00026a013", "article-title": "Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT)", "volume": "38", "author": "Springer", "year": "1995", "journal-title": "J. Med. Chem."}, {"issue": "14", "key": "10.1002/9783527682423.ch18-BIB50|cit50", "first-page": "3287", "article-title": "ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts", "volume": "56", "author": "Blakey", "year": "1996", "journal-title": "Cancer Res."}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "764", "DOI": "10.1054/bjoc.2001.1947", "article-title": "Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue", "volume": "85", "author": "Monks", "year": "2001", "journal-title": "Br. J. Cancer"}, {"issue": "6", "key": "10.1002/9783527682423.ch18-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1038/sj.bjc.6600517", "article-title": "A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours", "volume": "87", "author": "Francis", "year": "2002", "journal-title": "Br. J. Cancer"}, {"issue": "1-2", "key": "10.1002/9783527682423.ch18-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1155/2000/672706", "article-title": "Clinical applications of phage-derived sFvs and sFv fusion proteins", "volume": "16", "author": "Chester", "year": "2000", "journal-title": "Dis. Markers"}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/1380-2933(96)00033-4", "article-title": "In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein", "volume": "2", "author": "Michael", "year": "1996", "journal-title": "Immunotechnology"}, {"issue": "4", "key": "10.1002/9783527682423.ch18-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1002/(SICI)1097-0215(20000215)85:4<571::AID-IJC20>3.0.CO;2-1", "article-title": "Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein", "volume": "85", "author": "Bhatia", "year": "2000", "journal-title": "Int. J. Cancer"}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "1006", "DOI": "10.1038/nprot.2006.126", "article-title": "Production of recombinant protein in Pichia pastoris by fermentation", "volume": "1", "author": "Tolner", "year": "2006", "journal-title": "Nat. Protoc."}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1093/glycob/cwh001", "article-title": "Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein", "volume": "14", "author": "Medzihradszky", "year": "2004", "journal-title": "Glycobiology"}, {"issue": "2", "key": "10.1002/9783527682423.ch18-BIB58|cit58", "first-page": "814", "article-title": "Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy", "volume": "11", "author": "Sharma", "year": "2005", "journal-title": "Clin. Cancer Res."}, {"issue": "21", "key": "10.1002/9783527682423.ch18-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "6509", "DOI": "10.1158/1078-0432.CCR-06-0769", "article-title": "A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug", "volume": "12", "author": "Mayer", "year": "2006", "journal-title": "Clin. Cancer Res."}, {"issue": "1-3", "key": "10.1002/9783527682423.ch18-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1007/BF02789482", "article-title": "Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial", "volume": "21", "author": "Sharma", "year": "1992", "journal-title": "Cell Biophys."}, {"issue": "6", "key": "10.1002/9783527682423.ch18-BIB61|cit61", "first-page": "3156", "article-title": "Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT", "volume": "28", "author": "Bagshawe", "year": "1996", "journal-title": "Transplant. Proc."}, {"issue": "12", "key": "10.1002/9783527682423.ch18-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "2402", "DOI": "10.1038/sj.bjc.6601888", "article-title": "Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)", "volume": "90", "author": "Mayer", "year": "2004", "journal-title": "Br. J. Cancer"}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1002/1615-9861(200203)2:3<271::AID-PROT271>3.0.CO;2-W", "article-title": "A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics", "volume": "2", "author": "Spencer", "year": "2002", "journal-title": "Proteomics"}, {"issue": "4", "key": "10.1002/9783527682423.ch18-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1586/1744666X.1.4.549", "article-title": "Overcoming the immunologic response to foreign enzymes in cancer therapy", "volume": "1", "author": "Chester", "year": "2005", "journal-title": "Expert Rev. Clin. Immunol."}, {"issue": "11", "key": "10.1002/9783527682423.ch18-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "1791", "DOI": "10.1158/1535-7163.MCT-05-0189", "article-title": "A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy", "volume": "4", "author": "Harding", "year": "2005", "journal-title": "Mol. Cancer Ther."}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1021/bc980057z", "article-title": "Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843", "volume": "10", "author": "Wolfe", "year": "1999", "journal-title": "Bioconjugate Chem."}, {"issue": "5", "key": "10.1002/9783527682423.ch18-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1038/sj.bjc.6600143", "article-title": "A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug", "volume": "86", "author": "de Graaf", "year": "2002", "journal-title": "Br. J. Cancer"}, {"issue": "3", "key": "10.1002/9783527682423.ch18-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1089/108497803322285099", "article-title": "Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT)", "volume": "18", "author": "Biela", "year": "2003", "journal-title": "Cancer Biother. Radiopharm."}, {"issue": "20", "key": "10.1002/9783527682423.ch18-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "6293", "DOI": "10.1021/bi0361160", "article-title": "Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy", "volume": "43", "author": "Heinis", "year": "2004", "journal-title": "Biochemistry"}, {"issue": "1", "key": "10.1002/9783527682423.ch18-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1093/protein/gzh007", "article-title": "Enzyme-like proteins from an unselected library of designed amino acid sequences", "volume": "17", "author": "Wei", "year": "2004", "journal-title": "Protein Eng. Des. Sel."}, {"issue": "12", "key": "10.1002/9783527682423.ch18-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "1281", "DOI": "10.1016/j.chembiol.2005.09.012", "article-title": "High-throughput screening of enzyme libraries: thiolactonases evolved by fluorescence-activated sorting of single cells in emulsion compartments", "volume": "12", "author": "Aharoni", "year": "2005", "journal-title": "Chem. Biol."}, {"issue": "10", "key": "10.1002/9783527682423.ch18-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1093/protein/gzs044", "article-title": "Design and analysis of immune-evading enzymes for ADEPT therapy", "volume": "25", "author": "Osipovitch", "year": "2012", "journal-title": "Protein Eng. Des. Sel."}], "container-title": ["Handbook of Therapeutic Antibodies"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9783527682423.ch18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T20:47:53Z", "timestamp": 1565729273000}, "score": 23.340984, "issued": {"date-parts": [[2014, 8, 12]]}, "ISBN": ["9783527682423", "9783527329373"], "references-count": 72, "URL": "http://dx.doi.org/10.1002/9783527682423.ch18", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:13:51Z", "timestamp": 1574115231270}, "reference-count": 67, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 2, 1]], "date-time": "1999-02-01T00:00:00Z", "timestamp": 917827200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Resistance Updates"], "published-print": {"date-parts": [[1999, 2]]}, "DOI": "10.1054/drup.1998.0062", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T14:55:24Z", "timestamp": 1032447324000}, "page": "30-37", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma"], "prefix": "10.1054", "volume": "2", "author": [{"given": "Motoo", "family": "Nagane", "sequence": "first", "affiliation": []}, {"given": "H.-J.Su", "family": "Huang", "sequence": "additional", "affiliation": []}, {"given": "Webster K.", "family": "Cavenee", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Resistance Updates"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1368764698900620?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1368764698900620?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 11]], "date-time": "2019-04-11T20:24:11Z", "timestamp": 1555014251000}, "score": 22.87231, "issued": {"date-parts": [[1999, 2]]}, "references-count": 67, "journal-issue": {"published-print": {"date-parts": [[1999, 2]]}, "issue": "1"}, "alternative-id": ["S1368764698900620"], "URL": "http://dx.doi.org/10.1054/drup.1998.0062", "ISSN": ["1368-7646"], "issn-type": [{"value": "1368-7646", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T15:53:38Z", "timestamp": 1575388418358}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 11, 1]], "date-time": "2013-11-01T00:00:00Z", "timestamp": 1383264000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[2013, 11]]}, "DOI": "10.1016/s0959-8049(13)70105-9", "type": "journal-article", "created": {"date-parts": [[2013, 11, 1]], "date-time": "2013-11-01T19:24:26Z", "timestamp": 1383333866000}, "page": "S7-S8", "source": "Crossref", "is-referenced-by-count": 0, "title": ["SP027 RAS mutations as markers of resistance for colorectal cancer patients treated with the anti-EGFR monoclonal antibody panitumumab"], "prefix": "10.1016", "volume": "49", "author": [{"given": "K.", "family": "Oliner", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804913701059?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804913701059?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 11]], "date-time": "2018-10-11T03:21:21Z", "timestamp": 1539228081000}, "score": 22.807175, "issued": {"date-parts": [[2013, 11]]}, "references-count": 0, "alternative-id": ["S0959804913701059"], "URL": "http://dx.doi.org/10.1016/s0959-8049(13)70105-9", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}], "subject": ["Cancer Research", "Oncology"]}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:57:35Z", "timestamp": 1574816255716}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009, 6, 1]]}, "DOI": "10.21236/ada509995", "type": "report", "created": {"date-parts": [[2017, 7, 28]], "date-time": "2017-07-28T12:05:03Z", "timestamp": 1501243503000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["PROSPECT (Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification"], "prefix": "10.21236", "author": [{"given": "Wuan K.", "family": "Hong", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 28]], "date-time": "2017-07-28T12:05:03Z", "timestamp": 1501243503000}, "score": 22.717201, "subtitle": [""], "issued": {"date-parts": [[2009, 6, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada509995"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:01:56Z", "timestamp": 1574830916003}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 6, 1]]}, "DOI": "10.21236/ada581682", "type": "report", "created": {"date-parts": [[2017, 9, 6]], "date-time": "2017-09-06T22:44:34Z", "timestamp": 1504737874000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["PROSPECT: Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification"], "prefix": "10.21236", "author": [{"given": "Wuan K.", "family": "Hong", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 9, 6]], "date-time": "2017-09-06T22:44:34Z", "timestamp": 1504737874000}, "score": 22.717201, "subtitle": [""], "issued": {"date-parts": [[2012, 6, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada581682"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}